HEMOSNOW: A revolution in haemostatic technology to stop bleeding in delicate surgery and enhance patient recovery

Project description

Helping surgeons to stop excessive bleeding

In major surgery, excessive blood loss is associated with longer hospital stays, delayed recovery and increased mortality. Haemostatic agents can be used to control bleeding. However, most haemostats currently used by surgeons have lengthy preparation times, are difficult to apply and stick to surgical instruments limiting their suitable application. In this context, the EU-funded HEMOSNOW project will conduct the clinical study and upscale production to commercialise a unique haemostatic powder formulation capable of stopping minimum (oozing) and mild (pooling) bleeding (level 1 & 2 bleeding on the SPOTGRADE scale). It is a collagen-based powder that is ready to use and stops bleeding within 6 minutes.

Fields of science

• social sciences › sociology › demography › mortality
• medical and health sciences › clinical medicine › surgery
• social sciences › political sciences › political transitions › revolutions
• engineering and technology › civil engineering › water engineering › urban drainage

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

BIOM'UP SA

Net EU contribution

€ 50 000,00

Address

8, Allee Irene Joliot Curie
69800 Saint-priest
France

Region

Auvergne-Rhône-Alpes › Rhône-Alpes › Rhône

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 21 429,00